Works matching DE "TIPRANAVIR (Drug)"


Results: 22
    1
    2

    Effects of enzyme inducers efavirenz and tipranavir/ritonavir on the pharmacokinetics of the HIV integrase inhibitor dolutegravir.

    Published in:
    European Journal of Clinical Pharmacology, 2014, v. 70, n. 10, p. 1173, doi. 10.1007/s00228-014-1732-8
    By:
    • Song, Ivy;
    • Borland, Julie;
    • Chen, Shuguang;
    • Guta, Phyllis;
    • Lou, Yu;
    • Wilfret, David;
    • Wajima, Toshihiro;
    • Savina, Paul;
    • Peppercorn, Amanda;
    • Castellino, Stephen;
    • Wagner, David;
    • Hosking, Louise;
    • Mosteller, Michael;
    • Rubio, Justin;
    • Piscitelli, Stephen
    Publication type:
    Article
    3
    4
    5

    2018 update to the HIV-TRePS system: the development of new computational models to predict HIV treatment outcomes, with or without a genotype, with enhanced usability for low-income settings.

    Published in:
    2018
    By:
    • Revell, Andrew D;
    • Wang, Dechao;
    • Perez-Elias, Maria-Jesus;
    • Wood, Robin;
    • Cogill, Dolphina;
    • Tempelman, Hugo;
    • Hamers, Raph L;
    • Reiss, Peter;
    • Sighem, Ard I van;
    • Rehm, Catherine A;
    • van Sighem, Ard I;
    • Pozniak, Anton;
    • Montaner, Julio S G;
    • Lane, H Clifford;
    • Larder, Brendan A;
    • RDI Data and Study Group
    Publication type:
    journal article
    6

    Highly multidrug-resistant HIV: clonal analysis and therapeutic strategies.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. 12, p. 2882, doi. 10.1093/jac/dkt272
    By:
    • Todesco, Eve;
    • Sayon, Sophie;
    • Fourati, Slim;
    • Tubiana, Roland;
    • Simon, Anne;
    • Ktorza, Nadine;
    • Schneider, Luminita;
    • Peytavin, Gilles;
    • Malet, Isabelle;
    • Van den Eede, Peter;
    • Katlama, Christine;
    • Calvez, Vincent;
    • Marcelin, Anne-Genevieve;
    • Wirden, Marc
    Publication type:
    Article
    7

    Efficacy and safety of raltegravir in treatment-experienced HIV-1-infected patients switching from enfuvirtide-based regimens: 48 week results of the randomized EASIER ANRS 138 trial.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2011, v. 66, n. 9, p. 2099
    By:
    • Gallien, Sébastien;
    • Braun, Joséphine;
    • Delaugerre, Constance;
    • Charreau, Isabelle;
    • Reynes, Jacques;
    • Jeanblanc, François;
    • Verdon, Renaud;
    • de Truchis, Pierre;
    • May, Thierry;
    • Madelaine-Chambrin, Isabelle;
    • Aboulker, Jean-Pierre;
    • Molina, Jean-Michel
    Publication type:
    Article
    8
    9
    10
    11

    Use of Third Line Antiretroviral Therapy in Latin America.

    Published in:
    PLoS ONE, 2014, v. 9, n. 9, p. 1, doi. 10.1371/journal.pone.0106887
    By:
    • Cesar, Carina;
    • Shepherd, Bryan E.;
    • Jenkins, Cathy A.;
    • Ghidinelli, Massimo;
    • Castro, Jose Luis;
    • Veloso, Valdiléa Gonçalves;
    • Cortes, Claudia P.;
    • Padgett, Denis;
    • Crabtree-Ramirez, Brenda;
    • Gotuzzo, Eduardo;
    • Fink, Valeria;
    • Duran, Adriana;
    • Sued, Omar;
    • McGowan, Catherine C.;
    • Cahn, Pedro
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20
    21

    Tipranavir/Ritonavir (500/200 mg and 500/100 mg) Was Virologically Non-Inferior to Lopinavir/Ritonavir (400/100 mg) at Week 48 in Treatment-Naïve HIV-1-Infected Patients: A Randomized, Multinational, Multicenter Trial.

    Published in:
    PLoS ONE, 2016, v. 11, n. 1, p. 1, doi. 10.1371/journal.pone.0144917
    By:
    • Cooper, David A.;
    • Cordery, Damien V.;
    • Zajdenverg, Roberto;
    • Ruxrungtham, Kiat;
    • Arastéh, Keikawus;
    • Bergmann, Frank;
    • Neto, José L. de Andrade;
    • Scherer, Joseph;
    • Chaves, Ricardo L.;
    • Robinson, Patrick;
    • null, null
    Publication type:
    Article
    22